Empowering W.H.O. as a Global Authority and Centralized Pool of Resources for Speedy Development of Orphan drugs at Reduced Cost
Journal Title: Journal of Pharmaceutical Sciences and Research - Year 2010, Vol 2, Issue 12
Abstract
Orphan drugs are the drugs that are used to treat a rare disease affecting a very small segment of population. Since new drug development and approval process requires an expenditure of about US$ 1 billion and a time of 10-12 years, therefore, no company is willing to come forward for development of an orphan drug because of low returns. As a consequence rare diseases are becoming global menace. Incentives offered by developed countries i.e. U.S.A., EU & Japan are inadequate. Even no single developed country can afford development of large number of orphan drugs owing to increased cost of drug development amalgamated with low financial return for thousands of rare diseases. There is a strong need for adopting unified approach by creating a centralized pool of resources under the auspices of World Health Organization (W.H.O.) for speedy development of orphan drugs. Developed countries like U.S.A, EU and developing countries with emerging economies such as China and India can play vital role in such a unified approach. This will naturally avoid unnecessary duplication of efforts, resources and facilitate speedy development of orphan drugs at a reduced cost for benefit of all concerned at a global level. People residing in both the developing counties as well as developed world will be equally benefited by this approach. Approval by W.H.O. alone should suffice the purpose for introduction of new orphan drugs all over the world as a special case in order to avoid unnecessary delays and to save precious lives.
Authors and Affiliations
Vipul K. Gupta , Promila Gupta , Rajendra K. Songara
Keywords
Related Articles
- EP ID EP150116
- DOI -
- Views 118
- Downloads 0
Formulation and Evaluation of Microparticles of Metronidazole
In the present study it was aimed to formulate delayed release Metronidazole microparticles, which will have enteric as well as sustained release properties. For the preparation of Metronidazole microparticles...
Polysaccharide gum matrix tablets for oral controlled delivery of Cimetidine
Matrix-based tablets using 40 %w/w grewia gum were prepared by direct compression to contain cimetidine as novel drug. The formulations were compared with similar formulations using hydroxypropyl methylce...
Formulation and Evaluation of Polysaccharide Based Biopolymer – an Ecofriendly Alternative for Synthetic Polymer.
The Main objective of the present study was to develop polysaccharide based biopolymer films with similar properties comparable to synthetic polymer films using waste materials of plant origin ,especially by the utilizat...
Moringa oleifera: a natural gift-A review
Moringa oleifera, Lam {Syn M.pterygosperma Gaertn} usually mentioned in literature as Moringa, is a natural as well as cultivated variety of the genus Moringa belonging to family Moringaceae .It is one of the riches...
Specific and Simple HPLC Assay of Ecofriendly Meloxicam in Pharmaceutical Formulations
A simple, precise, specific ,robust and rapid HPLC assay for the of measurement meloxicam in pharmaceutical formulations was developed and validated at Department of Pharmacy and Central Quality Assurance...